At the news
? NEUTRALIMPACT 3/10 PRESS-RELEASE filed Mar 19, 2026 at 08:00 ET
Fulcrum Therapeutics (FULC) announced a partnership with MedicAlert Foundation and the Sickle Cell Disease Association of America (SCDAA) to expand access to emergency medical information for sickle cell disease (SCD) patients via MedicAlert’s Smart Medical ID Cards. The program links patient-specific care plans to QR codes, enabling faster clinical decisions during ED visits. Fulcrum is funding the expansion but no financial terms were disclosed.
- Fulcrum Therapeutics partnered with MedicAlert and SCDAA to expand emergency care access for sickle cell disease patients.
- The program provides patients with a MedicAlert Smart Medical ID Card that links to a digital health profile containing pain plans, medications, allergies, and hematologist contacts.
- No financial terms, dollar amounts, or share impacts were disclosed.
- This is a non-commercial, patient-support initiative aimed at improving care coordination, not a product launch or regulatory event.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access